• Explain the objectives of upcoming trials that will investigate optimal dosing and duration of antiplatelet agents
• Identify the properties of novel antiplatelet agents that may be beneficial
• Balance the efficacy of antiplatelet therapy with the risk for bleeding

Click here to listen to this podcast. (Or, to download the audio file, right click onthe link and choose "Save Target As".)

• Recognize the optimal dosing and duration of antiplatelet agents in a range of patient types (young vs old, women vs men, low vs high BMI) to prevent ischemic events
• Balance the efficacy of an antiplatelet therapy with the risk for bleeding
• Identify the risks and benefits of different antiplatelet and antithrombotic therapies

• Therapeutic advances in atniplatelet and antithrombotic therapy in acute coronary syndrome
• Clinical outcomes following percutaneous coronary intervention
• Late-breaking trial data

Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)

• Recognize the optimal dosing and duration of antiplatelet agents in a range of patient types (young vs old, women vs men, low vs high BMI) to prevent ischemic events
• Balance the efficacy of an antiplatelet therapy with the risk for bleeding
• Identify the risks and benefits of different antiplatelet and antithrombotic therapies

• Therapeutic advances in antiplatelet and antithrombotic therapy in acute coronary syndrome
• Clinical outcomes following percutaneous coronary intervention
• Late-breaking trial data

• Therapeutic advances in antiplatelet and antithrombotic therapy
• Clinical outcomes following stent thrombosis
• Late-breaking trial data